Hirokuni Takano

1.5k total citations
37 papers, 758 citations indexed

About

Hirokuni Takano is a scholar working on Reproductive Medicine, Surgery and Obstetrics and Gynecology. According to data from OpenAlex, Hirokuni Takano has authored 37 papers receiving a total of 758 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Reproductive Medicine, 14 papers in Surgery and 12 papers in Obstetrics and Gynecology. Recurrent topics in Hirokuni Takano's work include Ovarian cancer diagnosis and treatment (19 papers), Endometrial and Cervical Cancer Treatments (12 papers) and Cervical Cancer and HPV Research (6 papers). Hirokuni Takano is often cited by papers focused on Ovarian cancer diagnosis and treatment (19 papers), Endometrial and Cervical Cancer Treatments (12 papers) and Cervical Cancer and HPV Research (6 papers). Hirokuni Takano collaborates with scholars based in Japan, Canada and United States. Hirokuni Takano's co-authors include Aikou Okamoto, Kyosuke Yamada, David G. Huntsman, David G. Ginzinger, Joe W. Gray, Anna Lapuk, Jennifer L. Santos, Yinghui Guan, Jackie L. Stilwell and Mamie Yu and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Clinical Cancer Research.

In The Last Decade

Hirokuni Takano

32 papers receiving 751 citations

Peers

Hirokuni Takano

ONCOL

Alexandros Laios United Kingdom

Yasushi Iida Japan

E Sun Paik South Korea

Asima Mukhopadhyay India

Camilla Nero Italy

Lan Peng United States

Liting Qian China

J P Basuyau France

Jørn Andersen Denmark

Olga C.J. Schuurbiers Netherlands

Alexandros Laios United Kingdom

Hirokuni Takano

499 ×1.6

448 ×1.5

297 ×1.2

209 ×1.5

127 ×1.0

ONCOL

Citations per year, relative to Hirokuni Takano Hirokuni Takano (= 1×) peers Alexandros Laios

Countries citing papers authored by Hirokuni Takano

Since Specialization

Citations

This map shows the geographic impact of Hirokuni Takano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hirokuni Takano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hirokuni Takano more than expected).

Fields of papers citing papers by Hirokuni Takano

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hirokuni Takano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hirokuni Takano. The network helps show where Hirokuni Takano may publish in the future.

Co-authorship network of co-authors of Hirokuni Takano

This figure shows the co-authorship network connecting the top 25 collaborators of Hirokuni Takano. A scholar is included among the top collaborators of Hirokuni Takano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hirokuni Takano. Hirokuni Takano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tate, Shinichi, Toshiyuki Seki, Kyoko Nishikimi, et al.. (2025). Bevacizumab in frontline chemotherapy improved the survival outcome for advanced ovarian clear cell carcinoma: a multicenter retrospective analysis. Journal of Gynecologic Oncology. 36(5). e80–e80. 1 indexed citations

Nishio, Shin, Tadaaki Nishikawa, Masahiko Mori, et al.. (2025). Durvalumab plus carboplatin/paclitaxel followed by durvalumab with or without olaparib as first-line treatment for newly diagnosed advanced or recurrent endometrial cancer: Japan subset from the phase III DUO-E trial. Journal of Gynecologic Oncology. 36(4). e118–e118.

Seki, Toshiyuki, Ryosuke Saito, Yuichiro Tsukada, et al.. (2025). The detrimental impact of diverting ileostomy on renal function after tumor debulking surgery for advanced ovarian cancer. Gynecologic Oncology. 200. 14–21. 1 indexed citations

Ueda, Akihiko, Hidekatsu Nakai, Tomoyuki Otani, et al.. (2024). Artificial Intelligence-Based Histopathological Subtyping of High-Grade Serous Ovarian Cancer. American Journal Of Pathology. 194(10). 1913–1923. 1 indexed citations

Takahashi, Kazuaki, Hiroshi Tanabe, Motoaki Saito, et al.. (2024). A retrospective study of dose-dense paclitaxel and carboplatin plus bevacizumab as first-line treatment of advanced epithelial ovarian cancer. Journal of Gynecologic Oncology. 35(6). e76–e76. 2 indexed citations

Nishio, Shin, Kazuhiro Takehara, Shinya Sato, et al.. (2024). Re-administration of platinum-based chemotherapy for recurrent endometrial cancer: an ancillary analysis of the SGSG-012/GOTIC-004/Intergroup study. International Journal of Clinical Oncology. 29(10). 1594–1601.

Takenaka, Masataka, Yasushi Iida, Nozomu Yanaihara, et al.. (2021). Re-thinking the prognostic significance of positive peritoneal cytology in endometrial cancer. Gynecologic Oncology. 161(1). 135–142. 15 indexed citations

Ogawa, Kohei, Toshiyuki Seki, Masataka Takenaka, et al.. (2021). Scoring Systems of Peritoneal Dissemination for the Prediction of Operative Completeness in Advanced Ovarian Cancer. Anticancer Research. 42(1). 115–124. 5 indexed citations

Seki, Toshiyuki, et al.. (2021). A case of relapsing aseptic meningitis under excellent tumor response to pembrolizumab in microsatellite instability-high recurrent endometrial cancer. Gynecologic Oncology Reports. 38. 100885–100885.

10.

Saito, Motoaki, Yasushi Iida, Nozomu Yanaihara, et al.. (2020). Neoadjuvant Chemotherapy for Patients With Diaphragmatic Lesions: A Prognostic Postoperative Analysis. In Vivo. 34(3). 1277–1281. 1 indexed citations

11.

Kawakami, Eiryo, Junya Tabata, Nozomu Yanaihara, et al.. (2019). Application of Artificial Intelligence for Preoperative Diagnostic and Prognostic Prediction in Epithelial Ovarian Cancer Based on Blood Biomarkers. Clinical Cancer Research. 25(10). 3006–3015. 156 indexed citations

12.

Sasaki, Hiroshi, Kyosuke Yamada, Hirokuni Takano, et al.. (2019). Long term outcomes from lymphatic venous anastomosis after total hysterectomy to prevent postoperative lymphedema in lower limb. BMC Surgery. 19(1). 177–177. 11 indexed citations

13.

Matoda, Maki, Nobuhiro Takeshima, Hirofumi Michimae, et al.. (2018). Postoperative chemotherapy for node-positive cervical cancer: Results of a multicenter phase II trial (JGOG1067). Gynecologic Oncology. 149(3). 513–519. 28 indexed citations

14.

Takano, Hirokuni, Keiko Nakajima, Jiro Suzuki, et al.. (2018). Clinical associations of Trousseau's syndrome associated with cerebral infarction and ovarian cancer. Journal of Gynecologic Oncology. 29(5). e67–e67. 16 indexed citations

15.

Tanabe, Hiroshi, et al.. (2018). Retrospective analysis of sites of recurrence in stage I epithelial ovarian cancer. Journal of Gynecologic Oncology. 29(3). e37–e37. 18 indexed citations

16.

Komiyama, Shinichi, Kazuyoshi Kato, Hirokuni Takano, et al.. (2018). Bevacizumab combined with platinum–taxane chemotherapy as first-line treatment for advanced ovarian cancer: a prospective observational study of safety and efficacy in Japanese patients (JGOG3022 trial). International Journal of Clinical Oncology. 24(1). 103–114. 44 indexed citations

17.

Morisada, Tohru, Hirokuni Takano, Ikuko Sakamoto, et al.. (2017). CITRUS, cervical cancer screening trial by randomization of HPV testing intervention for upcoming screening: Design, methods and baseline data of 18,471 women. Cancer Epidemiology. 50(Pt A). 60–67. 11 indexed citations

18.

Yanagida, Satoshi, Michael S. Anglesio, Tayyebeh M. Nazeran, et al.. (2017). Clinical and genetic analysis of recurrent adult-type granulosa cell tumor of the ovary: Persistent preservation of heterozygous c.402C>G FOXL2 mutation. PLoS ONE. 12(6). e0178989–e0178989. 11 indexed citations

19.

Fujiwara, Hiroyuki, Mitsuaki Suzuki, Nobuhiro Takeshima, et al.. (2014). Evaluation of human epididymis protein 4 (HE4) and Risk of Ovarian Malignancy Algorithm (ROMA) as diagnostic tools of type I and type II epithelial ovarian cancer in Japanese women. Tumor Biology. 36(2). 1045–1053. 43 indexed citations

20.

Guan, Yinghui, Wen-Lin Kuo, Jackie L. Stilwell, et al.. (2007). Amplification of PVT1 Contributes to the Pathophysiology of Ovarian and Breast Cancer. Clinical Cancer Research. 13(19). 5745–5755. 295 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact